Chemical industry – Page 18
-
OpinionHow the pandemic might change drug research
Derek Lowe muses on some positive lessons learned
-
BusinessWhy manufacturing Covid vaccines at scale is hard
Exploring the pinch points vaccine makers face as they ramp up production
-
OpinionWhy are impurity regulations different for food and drugs?
The pharmaceutical and food industries should work together more closely on genotoxic impurities
-
FeatureFlow chemistry surges forward
The long-discussed technique could help make pharma manufacturing more distributed, finds Andy Extance, and create opportunities for chemists with the right skills
-
BusinessUniversity team’s silica coats stop vaccines spoiling at room temperature
Asel Sartbaeva hopes her pioneering ensilication technology will be adopted to store and transport pediatric vaccines to low-income countries
-
BusinessChromosol’s silicon photonics system tackles data transfer bottleneck
Technology for integrating lasers directly into photonic circuits could accelerate replacement of large and expensive optical systems
-
BusinessPolar storm paralyses US Gulf Coast petrochemical sector
Days after ‘icepocalypse’ hit Texas, 75% of US ethylene capacity was still offline, as was 70% of its polypropylene and 40% of propylene production
-
BusinessCoronavirus variants stymie success of monoclonal antibodies
Lab-made antibodies can treat and protect people from Covid-19 but are more likely to succeed when administered as a cocktail
-
BusinessBASF tightens austerity belt and closes plant in north of England
Political fallout over £1 billion Covid loan that preceded hexamethylene diamine plant closure
-
OpinionA rough guide to pharma partnership deals
Coronavirus vaccines are driving unusual collaborations with a range of benefits
-
WebinarGaining an edge through smarter experimentation
Learn how to double your R&D capacity and get more products to market in less time – and at a lower cost
-
BusinessBiggest venture yet of any pharma company into cannabis
Jazz Pharmaceuticals buys cannabinoid therapeutic firm for $7.2 billion, inheriting first plant-derived cannabinoid medicine ever approved by FDA
-
BusinessCovid vaccination efforts bolstered by trial results from J&J and Novavax
A miserable January ended with positive news on the vaccine front but new variants added complications
-
OpinionObserving the state’s transition
Sweeping changes on both sides of the Atlantic have yet to deliver on their promises
-
ArticlePittcon 2021: connections that matter
After 71 years as a physical event, Pittcon 2021 goes virtual on its 72nd birthday
-
BusinessPatent applications listing AI as an inventor run into legal problems
Artificial intelligence is increasingly being used to find new chemical compounds and repurpose drugs, but should laws be updated to protect the intellectual property of such discoveries?
-
BusinessHoxton Farms grows animal fat for meat substitutes
Covid-19 pandemic motivated friends to combine their expertise in cell biology and mathematical modelling, and realise company they had being discussing for years
-
BusinessDuPont and spinoffs reach $4bn settlement to resolve PFAS liability issues
DuPont, Chemours and Corteva have also reached an $83mn agreement to settle 95 pending personal injury cases in Ohio related to PFAS
-
OpinionRuling out the rule of five
Simple calculations for clinical trial success failed to find a winning formula
-
BusinessCan chemistry thaw the vaccine cold chain?
Covid-19 has highlighted the challenges of storing vaccines at their proper temperature. Angeli Mehta explores how scientists are trying to protect vaccines from heat degradation